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A 32-year-old female was admitted to our Medical Admissions Unit in April 2015 with 
a two week history of back and loin pain, heaviness in her thighs, intermittent fever 
and rigors.  Her past medical history included trigeminal neuralgia and pervasive 
anxiety, for which she had recently commenced quetiapine.  On examination, her 
temperature was 39oC, but there were no other abnormal physical findings.  The 
blood count and biochemical profile, including liver and renal function, were normal 
barring an elevated C-reactive protein (CRP) (118 mg/L, normal <4).  With a 
provisional diagnosis of acute pyelonephritis, she received broad-spectrum 
intravenous antibiotics; however, urine and blood cultures were sterile and CT of the 
renal tract was normal.  Considering a bacterial infection unlikely, we discontinued 
antibiotic therapy. 
 
Due to continuing fever and increasing discomfort in her back and thighs, we 
undertook additional tests: an elevated serum creatine kinase (CK) level (1827 U/L, 
range 25-200) raised the possibility of quetiapine-associated neuroleptic malignant 
syndrome, but her clinical status remained unchanged despite discontinuing 
quetiapine.  Repeat blood and urine analysis, throat swabs and cerebrospinal fluid 
failed to identify microorganisms including mycobacterial species.  Chest X-ray, and 
echocardiogram were normal.  Serum complement (C3/C4) levels were 
unremarkable and autoantibody screens negative.  One week into admission, her 
haemoglobin decreased (93g/L, range 120-160) and she developed a mild 
neutropenia (0·9 x 109/L, range 2·0-7·5) and thrombocytopenia (110 x 109/L, range 
150-400).  Iron studies supported inflammatory co-morbidity, but serum ferritin was 
disproportionately raised (15,507g/L, range 13-150) with marked fluctuation (nadir 
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2000 and peak 20,161) over the next week, corresponding to CK levels (445 U/L and 
1429 U/L respectively).  Serum lactate dehydrogenase (LDH) was also raised (632 
U/L, range 120-246).  Based on these results, we considered a myositis, possibly 
paraneoplastic, the likely cause of her symptoms despite undetectable anti-myositis 
antibodies.  The hyperferritinaemia and cytopenias also prompted consideration of 
haemophagocytic lymphohistiocytosis (HLH), often secondary in adults.1 
 
18F-FDG PET/CT imaging to identify malignancy showed no abnormalities in 
muscles or organs including lymph nodes, liver or spleen, but diffusely increased, 
non-homogeneous FDG up-take was observed in the axial skeleton (figure A).  MRI 
of the spine revealed marrow signal abnormalities corresponding to FDG-avid areas; 
patchy muscle and fascial oedema was also identified within the iliopsoas and 
obturator externus muscles bilaterally.  Needle electromyography of the hip 
adductors was abandoned due to pain; while no spontaneous activity was evident in 
the right quadriceps muscle, the presence of increased polyphasic motor unit 
potentials of short duration with refractory early recruitment suggested a myopathy.  
Muscle biopsy was technically challenging and showed non-specific small group 
atrophy, but no inflammatory, vasculitic, dystrophic, metabolic or mitochondrial 
myopathy.  Bone marrow biopsy was also performed: the marrow was cellular with 
fibrotic changes, but without morphological or immunohistochemical feaures of 
malignancy.  In addition, the absence of haemophagocytosis made the case for HLH 
less compelling (probability HScore 70%).2  With a provisional diagnosis of 
‘idiopathic inflammatory myopathy’, we decided to immunosuppress her with 
intravenous methylprednisolone. 
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Prior to the first dose of steroids, unexpectedly, an abnormal karyotype - 4345,XX,-
5,-10,-15,add(15)(p10),-22,+mar1,+mar2,+mar3[cp8]/46,XX[18] was identified in 
30% of marrow cells, suggesting an infiltrative neoplastic disorder.  Therefore, 10 
days after the initial biopsy, we undertook repeat marrow sampling to identify the 
malignant cell phenotype, but the morphological, immunohistochemical and 
cytogenetic features were unchanged.  She commenced steroids with no clinical 
improvement; this, along with progressive pancytopenia (haemoglobin 80g/L, 
neutrophils 0·5 x 109/L and platelets 50 x 109/L) made us consider a non-lymphoid, 
myeloid malignancy as the likely diagnosis.  Consequently, bone marrow was 
sampled for the third time in four weeks. 
 
On this occasion, the marrow was unaspirable and the trephine biopsy showed near-
total effacement of the marrow by a necrotic, high-grade tumour (figure B).  The 
expression of CD2, cytoplasmic CD3, CD30, perforin and TIA-1 indicated a 
malignant T-cell phenotype.  CD4, CD5, CD7, CD8, T-cell receptor (TCR)-gamma 
and ALK-1 were not detected, but TCR-beta F1 was expressed, which coupled with 
negative staining for TdT, excluded T-cell acute lymphoblastic leukaemia, and 
indicated a diagnosis of peripheral T-cell non Hodgkin lymphoma.3  We commenced 
her on multi-agent chemotherapy (CHOP) with rapid resolution of symptoms.  
Following three cycles, she achieved morphological and cytogenetic remission with 
normalisation of FDG signal on PET.  Given the atypical presentation and steroid-
insensitive disease, she was being considered for an allograft, but experienced 
disease-relapse that proved refractory to salvage chemotherapy.  Sadly, she died in 
December 2015. 
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The frequency of ‘B-symptoms’ as paraneoplastic phenomena in lymphoma is well-
recognised.4  In contrast, myositis, through unknown mechanisms is a rarer 
paraneoplastic occurrence with the potential to complicate the diagnostic process.5  
In our patient presenting with myositis, the diagnosis was additionally confounded by 
the anatomical restriction of non Hodgkin lymphoma (NHL) exclusively to the bone 
marrow, with no detectable disease at nodal or other extra-nodal sites even with 
sensitive PET/CT imaging.  Thus, while bone marrow examination in nodal high-
grade NHL is generally of prognostic, but not diagnostic utility,4 in our patient, the 
trephine biopsy proved to be most useful for the diagnosis.  Through this report, we 
intend to increase awareness of the unique disease-distribution and clinical features 
of rarer primary extra-nodal NHL that could result in diagnostic delay despite a 
concerted multi-disciplinary approach. 
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Figure.  Imaging and histopathological features of PTCL.  A.  A sagittaI 
reconstruction of the PET component of the 18F-FDG PET/CT study shows 
widespread but non-homogeneous increase in tracer uptake within marrow.  
Representative areas shown are the T10 vertebra (red arrow) and sternum (blue 
arrow).  Increased tracer uptake is also evident within the right anterior superior iliac 
spine (green arrow) in the axial image at the level of the pelvis (inset).  B.  
Haematoxylin-eosin stained section of the bone marrow biopsy (under a 40x 
objective) shows extensive infiltration with high-grade tumour, and in the inset, the 
immunohistochemical expression of CD3 indicates a T-cell malignancy.  The scale 
bars represent 0.1 mm. 
